Aurora Cannabis Inc

NASDAQ: ACB
$4.29
+$0.02 (+0.5%)
Closing Price on December 23, 2024

ACB Articles

Can Aurora Cannabis do anything to avoid the same fate as its peers that are circling the drain? Can anything the company does return it to its former glory?
It’s no secret that the cannabis industry has been smoked so far in 2020. Out of this group, Organigram seems to have fared the best. What comes next?
Something is moving Tilray stock far higher than other pot stocks. What can account for a 67% one-day jump in the cannabis company's share price?
After brutal sell-offs during the past year, some of the cannabis stocks have bounced back, a relief for many investors. Is Aphria set to be a winner?
For an industry that has been crushed since it entered the market, investors have to wonder if the pain is almost over for the cannabis stocks. Aphria may hold some answers.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Canadian cannabis grower CannTrust's headwinds include possible delisting from the New York Stock Exchange, overdue financial reports, a class-action lawsuit, black market competition and more.
Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in fiscal...
Although weed stocks have been getting crushed for a long time now, investors historically have made a lot of money bottom-fishing and value investing. Is Aurora Cannabis the place to be now?
The February 14 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
A receding tide for the marijuana industry has lowered all ships, and each stock has felt the sting since the market boom in the fall of 2018. If CannTrust can weather the storm, though, very blue...
After last year's dreadful results among Canada's pot growers, short sellers are all over Tilray and its peers. Is there much hope that Tilray may be able to hold on?
Tuesday's top analyst upgrades, downgrades and initiations included Aurora Cannabis, Biogen, EverQuote, Micron Technology, Nio, Nvidia, Palo Alto Networks, Tandem Diabetes Care, Tesla and Wix.com.
An analyst rating downgrade hit three marijuana stocks Monday morning, and a fourth was forced to announce a delay in filing quarterly documents with the appropriate U.S. and Canadian regulators.
Friday's top analyst upgrades, downgrades and initiations included Alkermes, Aurora Cannabis, BlackRock, Duke Energy, Nvidia, Ralph Lauren, SunPower, Veeva Systems and Yelp.